Public release date: 29-Feb-2012 [ | E-mail | Share ] Contact: Veronika Sexl veronika.sexl@vetmeduni.ac.at 43-125-077-2910 University of Veterinary Medicine — Vienna Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University of Veterinary Medicine, Vienna has pointed the finger strongly at loss or inactivation of the transcription factor STAT1. The results are published in the current issue of the journal Oncotarget
NORTH BRUNSWICK, N.J.–(BUSINESS WIRE)– Ross University School of Medicine and Ross University School of Veterinary Medicine today announced that Dr. Donald Smith has been named to the schools Board of Trustees. Dr.
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will release 2011 fourth quarter and year-end results on Thursday, March 1st after the market closes.
Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight. From day one they have embraced the transparency that this program requires.
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/48cbd2/intelligent_nanoma) has announced the addition of John Wiley and Sons Ltd’s new book “Intelligent Nanomaterials” to their offering. Smart and intelligent nanomaterials are currently in sharp focus in materials research as their properties are increasingly becoming more understood. This large and fairly comprehensive volume includes thirty chapters divided into four main areas: Inorganic materials, organic materials, composite materials, and biomaterials
SEATTLE–(BUSINESS WIRE)– Natural Molecular Testing Corp. (NMTC), a company providing groundbreaking clinical molecular testing and services in the medical genomics field, today announced that Karthikeshwar Kasirajan, M.D., has joined the company as Chief Medical Officer
Kidney hospital comes into operation at Bhaktapur Hospital A Kidney Hospital (human organ transplant center) has come into operation in the building at the premises of Bhaktapur Hospital, which remained vacant for the past three years after construction at a cost of Rs. 90 million, RSS reports
Kidney Cancer Canada calls for survivorship care plans to address the unique needs of kidney cancer patients TORONTO, Feb. 29, 2012 /CNW/ – According to a recent survey commissioned by Kidney Cancer Canada (KCC), there is a disconnect between what information urologists indicate they are communicating to kidney cancer patients following surgery, and what patients and their caregivers say they remember receiving
Type 2 diabetes is Australia’s leading cause of chronic kidney disease so doctors should give urgent priority to kidney testing and controlling diabetic patients’ blood sugar levels, researchers say. Kidney Health Australia says half the Australians who have type 2 diabetes suffer from chronic kidney disease but most do not have their kidney health routinely tested. Many also live with blood sugar levels that accelerate the loss of kidney function.
23-02-2012 17:49 Homeopathic remedies at Ez.com Holistic definitions of alternative medicine, integrative medicine, energy medicine. Discover what’s really working and healing and what’s just hype. youtu.be – created at goanimate.com
Published on February 29, 2012 at 2:20 AM Scientists from Trinity College Dublin have discovered a new ‘off switch’ in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. The findings are published this week in the journal Nature Communications
A team of scientists lead by researchers at Intermountain Medical Center has created a formula for using genetics to customize doses of a widely used, but dangerous, blood thinner.
ALISO VIEJO, Calif. & BALTIMORE–(BUSINESS WIRE)– Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announces specific results from one of three recent diagnoses using its proprietary new Clinical Diagnostic Exome. Four individuals with rare genetic conditions for which the cause could not previously be identified were successfully diagnosed, three at Kennedy Krieger Institute in Baltimore and one at a large, Ivy League-affiliated university hospital in New York City.
14-11-2011 17:13 Website qdragon.info Shirts and Stuff www.zazzle.com My twitter twitter.com Like Brainstorm on Facebook www.facebook.com Medical News tinyurl.com Biotechnology News tinyurl.com Physics News tinyurl.com Hosted by www.youtube.com